New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway - PubMed (original) (raw)

Review

New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway

John J O'Shea et al. Curr Opin Rheumatol. 2005 May.

Abstract

Purpose of review: Numerous immunosuppressants are available, but their adverse effects related to actions on nonlymphoid cells is problematic. Cytokines are key regulators of immune and inflammatory responses, and blocking their actions has become an important modality in treating autoimmune disorders. This review will discuss strategies to develop novel immunosuppressants that arise from advances in the understanding of cytokine signaling.

Recent findings: It is now recognized that large number of cytokines exert their effect by binding to receptors that activate the Janus kinase/signal transducer and activator of transcription pathway, so targeting intracellular signaling pathways is a logical strategy. A selective inhibitor of Janus kinase 3 has now been generated and is effective for transplant rejection in nonhuman primates and other models. Advances have also been made in understanding the functions of Stat family transcription factors, and approaches to interfering with the action of these DNA binding proteins are being devised. In addition, the identification of negative regulators of cytokine signaling offers additional therapeutic opportunities.

Summary: A selective inhibitor of Janus kinase 3 has now been generated and likely represents a new class of effective immunosuppressants. Strategies for targeting signal transducers and activators of transcription pathway are being intensively studied at present and hold potential promise. Multiple endogenous mechanisms exist for negatively regulating cytokine signaling; whether novel therapies can be devised that exploit these mechanisms remains to be determined.

PubMed Disclaimer

Cited by

Anti-inflammatory activity of compounds isolated from Astragalus sinicus L. in cytokine-induced keratinocytes and skin.
Kim BH, Oh I, Kim JH, Jeon JE, Jeon B, Shin J, Kim TY. Kim BH, et al. Exp Mol Med. 2014 Mar 21;46(3):e87. doi: 10.1038/emm.2013.157. Exp Mol Med. 2014. PMID: 24651533 Free PMC article.
An overview of the immunopathology of human paracoccidioidomycosis.
Benard G. Benard G. Mycopathologia. 2008 Apr-May;165(4-5):209-21. doi: 10.1007/s11046-007-9065-0. Mycopathologia. 2008. PMID: 18777630 Review.
The function of cancer-shed gangliosides in macrophage phenotype: involvement with angiogenesis.
Chung TW, Choi HJ, Park MJ, Choi HJ, Lee SO, Kim KJ, Kim CH, Hong C, Kim KH, Joo M, Ha KT. Chung TW, et al. Oncotarget. 2017 Jan 17;8(3):4436-4448. doi: 10.18632/oncotarget.13878. Oncotarget. 2017. PMID: 28032600 Free PMC article.
Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
Dang C, Lu Y, Chen X, Li Q. Dang C, et al. Front Immunol. 2021 Apr 13;12:650708. doi: 10.3389/fimmu.2021.650708. eCollection 2021. Front Immunol. 2021. PMID: 33927721 Free PMC article.
Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes.
Davoodi-Semiromi A, Wasserfall CH, Hassanzadeh A, Cooper-DeHoff RM, Wabitsch M, Atkinson M. Davoodi-Semiromi A, et al. Immunogenetics. 2013 Jan;65(1):83-90. doi: 10.1007/s00251-012-0659-4. Epub 2012 Oct 19. Immunogenetics. 2013. PMID: 23081744 Free PMC article.

New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway - PubMed (original) (raw)